Username Password
S&P 500: 1,322.48 Change: +0.41%
Zacks_Analysts
At least 5 active picks are required to calculate a P&P score.

Zacks_Analysts' Blog : Zacks Analyst Blog Highlights: Ciena Corp., Blyth Inc., Visa, Mead Johnson Nutrition Co. and Bristol-Myers Squibb Co. - Press Releases

Date December 16, 2009    Comments Comments (0)    Rate this post Recommend This Post (35)   
Bookmark and Share
Abuse this post  Report Abuse
Please report this as abuse only if you believe it violates People And Picks  Terms of Use
You must log in to send an abuse report.
Share ThisShare This

For Immediate Release


Chicago, IL – December 16, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Ciena Corp. (CIEN), Blyth Inc. (BTH), Visa (V), Mead Johnson Nutrition Co. (MJN) and Bristol-Myers Squibb Co. (BMY).


Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513


Here are highlights from Tuesday’s Analyst Blog:


Ciena Out of S&P 500


According to Standard and Poor’s latest realignment, Ciena Corp. (CIEN), the telecommunications equipment maker has been removed from the S&P 500 index and has been included in the S&P MidCap 400, replacing Blyth Inc. (BTH). Visa (V) will replace Ciena in the S&P 500 Index.


After the announcement, Ciena shares fell 6.64%, as negative investor sentiments loomed on the stock. The S&P 500 Index includes companies with market capital of above $5 billion. Since Ciena has a market cap of $1 billion, it is no longer a representative of the market index and thus has been removed.


Standard & Poor's added five other companies to its S&P 500, including Mead Johnson Nutrition Co. (MJN), which is being split off from Bristol-Myers Squibb Co. (BMY).


Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.


About Zacks Equity Research


Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.


Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.


Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517


About Zacks


Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.


Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Follow us on Twitter: http://twitter.com/zacksresearch


Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts


Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.


Contact:

Mark Vickery

Web Content Editor

312-265-9380

Visit: www.zacks.com


 


 

Zacks Investment Research
Tags : IL   CIEN   BTH   MJN   BMY   GUARANTEED  

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.
Sponsored Links